SCOPUS 정보 검색 플랫폼

Volumn 60, Issue 2, 2001, Pages 127-133

Irinotecan and mitomycin C in 5-fluorouracil-refractory colorectal cancer patients: A phase I/II study of the Southern Italy Cooperative Oncology Group

(10) Comella, Pasquale a Biglietto, Maria b Casaretti, Rossana a De Lucia, Luigi d Avallone, Antonio a Maiorino, Luigi c Di Lullo, Liberato e De Cataldis, Giuseppe f Rivellini, Flavia a Comella, Giuseppe a

a NATIONAL CANCER INSTITUTE (Italy)

b CARDARELLI HOSPITAL (Italy)

c San Gennaro Hospital (Italy)

d City Hospital (Italy)

e City Hospital (Italy)

f Unit Complessa di Pneumologia (Italy)

Author keywords

Chemotherapy, salvage; Colorectal cancer; Irinotecan; Mitomycin

Indexed keywords

ATROPINE; DEXAMETHASONE; FLUOROURACIL; HISTAMINE H3 RECEPTOR ANTAGONIST; IRINOTECAN; LOPERAMIDE; MITOMYCIN C;

ADULT; AGED; ALOPECIA; ANEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; DIARRHEA; DOSE RESPONSE; DRUG RESPONSE; FEBRILE NEUTROPENIA; FEMALE; HUMAN; MALE; MUCOSA INFLAMMATION; NAUSEA; NEUTROPENIA; PRIORITY JOURNAL; TREATMENT FAILURE;

ACTUARIAL ANALYSIS; ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CAMPTOTHECIN; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, NEOPLASM; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; MITOMYCIN; SALVAGE THERAPY; SURVIVAL ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 17744391551 PISSN: 00302414 EISSN: None Source Type: Journal
DOI: 10.1159/000055309 Document Type: Article

Times cited : (8)

References (25)

1
- 0031014627
- Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pre-treated with fluorouracil-based chemotherapy
- (1997) J Clin Oncol , vol.15 , pp. 251-260
- Rougier, P.¹ Bugat, R.² Douillard, J.Y.³ Culine, S.⁴ Suc, E.⁵ Brunet, P.⁶ Becouarn, Y.⁷ Ychou, M.⁸ Marty, M.⁹ Extra, J.M.¹⁰ Bonneterre, J.¹¹ Adenis, A.¹² Seitz, J.F.¹³ Ganem, G.¹⁴ Namer, M.¹⁵ Conroy, T.¹⁶ Negrier, S.¹⁷ Merrouche, Y.¹⁸ Burki, F.¹⁹ Mousseau, M.²⁰ Hérait, P.²¹ Mahjoubi, M.²² more..

2
- 0033558004
- A multcenter, phase II trial of weekly irinotecan (CPT-11) in patients with previously treated colorectal carcinoma
- (1999) Cancer , vol.85 , pp. 786-795
- Rothenberg, M.L.¹ Cox, J.V.² Devore, R.³ Hainsworth, J.D.⁴ Pazdur, R.⁵ Rivkin, S.E.⁶ Macdonald, J.S.⁷ Geyer, C.E.⁸ Sandbach, J.⁹ Wolf, D.L.¹⁰ Mohrland, J.S.¹¹ Elfring, G.L.¹² Miller, L.L.¹³ Von Hoff, D.D.¹⁴

3
- 0032585197
- Randomised trial of irinotecan versus fluorouracil by continuous infusion after fluorouracil failure in patients with metastatic colorectal cancer
- (1998) Lancet , vol.352 , pp. 1407-1412
- Rougier, P.¹ Van Cutsem, E.² Bajetta, E.³ Niederle, N.⁴ Possinger, K.⁵ Labianca, R.⁶ Navarro, M.⁷ Morant, R.⁸ Bleiberg, H.⁹ Wils, J.¹⁰ Awad, L.¹¹ Hérait, P.¹² Jacques, C.¹³

4
- 0032585232
- Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer
- (1998) Lancet , vol.352 , pp. 1413-1418
- Cunningham, D.¹ Pyrhonen, S.² James, R.D.³ Punt, C.J.A.⁴ Hickish, T.F.⁵ Heikkila, R.⁶ Johannesen, T.B.⁷ Starkhammar, H.⁸ Topham, C.A.⁹ Awad, L.¹⁰ Jacques, C.¹¹ Hérait, P.¹²

5
- 0030826929
- Topoisomerase I inhibitors: Review and update
- (1997) Ann Oncol , vol.8 , pp. 837-855
- Rothenberg, M.L.¹

6
- 0002832678
- Antitumor antibiotics and related compounds
- Perry MC (ed). Baltimore, Williams & Wilkins
- (1992) The Chemotherapy Sourcebook , pp. 318-358
- Riggs C.E., Jr.¹

7
- 0014590788
- Clinical study of mitomycin-C (NSC 26980) in colorectal cancer
- (1969) Cancer Chemother Rep , vol.53 , pp. 287-292
- Ansfield, F.¹

8
- 0014421328
- Mitomycin-C therapy in advanced gastrointestinal cancer
- (1968) JAMA , vol.20 , pp. 1045-1048
- Mortel, C.¹ Reitmeier, R.² Hahn, R.³

9
- 0005567554
- Effects of mitomycin-C in 346 patients with clinically advanced cancers
- (1968) Cancer Chemother Rep , vol.52 , pp. 67-69
- Moore, G.E.¹ Bross, I.D.J.² Ausman, S.³ Nadler, S.⁴ Jones R., Jr.⁵ Slack, N.⁶

10
- 0028118692
- Randomized clinical trial of mitomycin-C with or without pretreatment with WR-2721 in patients with advanced colorectal cancer
- (1994) Cancer Chemother Pharmacol , vol.33 , pp. 415-419
- Poplin, E.A.¹ LoRusso, P.² Lokich, J.J.³ Gullo, J.J.⁴ Leming, P.D.⁵ Schultz, J.J.⁶ Veach, S.R.⁷ McCulloch, W.⁸ Baker, L.⁹ Schein, P.¹⁰

11
- 0013806015
- The synergistic anti-neoplastic activity of combinations of mitomycin with either 6-thioguanine of 5-fluorouracil
- (1965) Cancer Res , vol.25 , pp. 1393-1400
- Sartorelli, A.C.¹ Booth, B.A.²

12
- 0024521170
- Time-dependent interactions between 5-fluorouracil and mitomycin C on human colon cancer cell line, HTC-8, in vitro
- (1989) Eur J Cancer Clin Oncol , vol.25 , pp. 571-572
- Rusello, O.¹ Romanini, A.² Civalleri, D.³ Rosso, R.⁴ Nicolin, A.⁵ Sobrero, A.⁶

13
- 0018075598
- 5FU infusion with mitomycin-C versus 5FU infusion with methyl-CCNU in the treatment of advanced colon cancer
- (1978) Cancer , vol.42 , pp. 1228-1233
- Buroker, T.¹ Kim, P.N.² Groppe, C.³ McCracken, J.⁴ O'Bryan, R.⁵ Panettiere, F.⁶ Coltman, C.⁷ Bottomley, R.⁸ Wilson, H.⁹ Bonnet, J.¹⁰ Thigpen, T.¹¹ Vaitkevicius, V.K.¹² Hoogstraten, B.¹³ Heilbrun, L.¹⁴

14
- 0018764872
- Treatment of advanced gastrointestinal cancer with 5-fluorouracil and mitomycin C
- (1979) Cancer , vol.43 , pp. 1598-1603
- Krauss, S.¹ Sonoda, T.² Solomon, A.³

15
- 35549013936
- Mitomycin-C added to schedule-specific biochemical modulation of 5-FU in advanced colorectal cancer (CRC)
- (2000) Proc/ASCO , vol.273 A
- Guglielmi, A.¹ Caroti, C.² Aschele, C.³ Labianca, R.⁴ Frassineti, G.L.⁵ Testore, F.⁶ Giuliani, R.⁷ Pessi, M.A.⁸ Turci, D.⁹ Grossi, F.¹⁰ Sobrero, A.¹¹

16
- 9844229067
- A prospective randomised trial of protracted venous infusion 5-fluorouracil with or without mitomycin C in advanced colorectal cancer
- (1997) Ann Oncol , vol.8 , pp. 995-1001
- Ross, P.¹ Norman, A.² Cunningham, D.³ Webb, A.⁴ Iveson, T.⁵ Padhani, A.⁶ Prendiville, J.⁷ Watson, M.⁸ Massey, A.⁹ Popescu, R.¹⁰ Oates, J.¹¹

17
- 0345425754
- Concurrent irinotecan and 5-fluorouracil plus levofolinic acid given every other week in the first-line management of advanced colorectal carcinoma: A phase I study of the Southern Italy Cooperative Oncology Group
- (1999) Ann Oncol , vol.10 , pp. 915-921
- Comella, P.¹ Casaretti, R.² De Vita, F.³ Avallone, A.⁴ Orditura, M.⁵ Petrillo, A.⁶ Gravina, A.⁷ Faranda, A.⁸ Comis, S.⁹ Comella, G.¹⁰ Catalano, G.¹¹

18
- 35549013833
- Biweekly treatment with either irinotecan (CPT-11) or Tomudex (TOM) followed by levo-leucovorin (LLV)-modulated 5FU bolus in advanced colorectal carcinoma (ACC)
- (2000) Proc ASCO , vol.257 A
- Comella, P.¹ De Vita, F.² De Lucia, L.³ Lorusso, V.⁴ Biglietto, M.⁵ Ianniello, G.P.⁶ Leo, S.⁷ Farris, A.⁸ Del Gaizo, F.⁹ Casaretti, R.¹⁰ Orditura, M.¹¹ Mancarella, S.¹² Catalano, G.¹³ Zeppetella, G.¹⁴ Brunetti, C.¹⁵ Buzzi, F.¹⁶ Comella, G.¹⁷

19
- 0000651974
- Final results of a phase I-II of CPT-11 (CPT) + mitomycin C (MMC) combination in patients with advanced cancer of the gastrointestinal system
- (1998) Proc ASCO , vol.268 A
- Gil-Delgado, M.A.¹ Antoine, E.C.² Bassot, V.³ Grapin, J.P.⁴ Benhammouda, A.⁵ Adam, R.⁶ Castaing, D.⁷ Bismuth, H.⁸ Khayat, D.⁹

20
- 0001095835
- Phase I/II study of irinotecan combined with mitomycin-C in patients with advanced gastric cancer
- (1999) Proc ASCO , vol.306 A
- Yamao, T.¹ Kazami, A.² Handa, T.³ Koizumi, K.⁴ Kai, S.⁵ Takemoto, N.⁶ Maruyama, M.⁷ Shirao, K.⁸ Muro, K.⁹ Yamada, Y.¹⁰ Sugano, K.¹¹ Matsumura, Y.¹² Shimada, Y.¹³

21
- 4243301656
- Combination of CPT-11 and mitomycin-C (MMC) for platinum refractory clear cell (CCA) and mucinous (MCA) adenocarcinoma of the ovary
- (1999) Proc ASCO , vol.361 A
- Shimizu, Y.¹ Umezawa, S.² Utsugi, K.³ Hasumi, K.⁴ Pujiwara, K.⁵ Kohno, I.⁶

22
- 0024536437
- Optimal two stage design for phase II clinical trials
- (1989) Control Clin Trials , vol.10 , pp. 1-10
- Simon, R.¹

23
- 0019365237
- Reporting results of cancer treatment
- (1981) Cancer , vol.47 , pp. 207-214
- Miller, A.B.¹ Hoogstraten, B.² Staquet, M.³ Winkler, V.⁴

24
- 0028853410
- Population pharmacokinetics and pharmaco-dynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials
- (1995) Ann Oncol , vol.6 , pp. 141-151
- Chabot, G.G.¹ Abigerges, D.² Catimel, G.³ Culine, S.⁴ De Forni, M.⁵ Extra, J.-M.⁶ Mahjoubi, M.⁷ Hérait, P.⁸ Armand, J.-P.⁹ Bugat, R.¹⁰ Clavel, M.¹¹ Marty, M.E.¹²

25
- 0010917253
- Pharmacokinetics and pharmacodynamics of irinotecan during a phase II clinical trial in colorectal cancer
- (1996) J Clin Oncol , vol.14 , pp. 2588-2696
- Canal, P.¹ Gay, C.² Dezeuze, A.³ Douillard, J.Y.⁴ Bugat, R.⁵ Brunet, R.⁶ Adenis, A.⁷ Hérait, P.⁸ Lokiec, F.⁹ Mathieu-Boue, A.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.